Noveko RD2 antimicrobial respirators obtain FFP2 classification

NewsGuard 100/100 Score

The Noveko(TM) RD2 respirators obtain FFP2 classification

Noveko International Inc. ("the Company") is pleased to announce that its subsidiary Noveko Inc. ("Noveko") has obtained FFP2 classification for its new model of antimicrobial respirators and can now bring them to market in all countries throughout the European Union. These respirators will be marketed as Noveko(TM) RD2 antimicrobial respirators.

The grant of this regulatory certification confirms that the Noveko(TM) RD2 antimicrobial respirators, which are considered personal protective equipment (PPE) pursuant to European Directive 89/686/EEC, respect the Directive's various health, safety and protection requirements, and have been designed and tested in compliance with the EN 149:2001+A1:2009 standard.

"We are very pleased with this additional recognition of the effectiveness and protection provided by our antimicrobial respirators. This certification not only gives us access to all countries in the European Union, but it will also facilitate the marketing of our respirators in several other territories that recognize these European standards," indicated Alain Bolduc, President and Chief Operating Officer of the Company.

The Company also points out that the necessary steps are continuing towards obtaining NIOSH certification in order to market its respirators in the United States.

Source:

NOVEKO INTERNATIONAL INC.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.